Coagulation function and mechanisms in various clinical phenotypes of patients with acquired factor V inhibitors.

about

Clot waveform analysis: Where do we stand in 2017?

P2860

Q45871584-524CA4DE-2699-441D-A48D-C213B63881D2

P2860

Coagulation function and mechanisms in various clinical phenotypes of patients with acquired factor V inhibitors.

Item

http://www.wikidata.org/entity/Q53033474

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Coagulation function and mecha ...... acquired factor V inhibitors.

@en

Coagulation function and mecha ...... acquired factor V inhibitors.

@nl

type

Item

label

Coagulation function and mecha ...... acquired factor V inhibitors.

@en

Coagulation function and mecha ...... acquired factor V inhibitors.

@nl

prefLabel

Coagulation function and mecha ...... acquired factor V inhibitors.

@en

Coagulation function and mecha ...... acquired factor V inhibitors.

@nl

P1476

Coagulation function and mecha ...... acquired factor V inhibitors.

@en

P2093

K Nogami

http://www.w3.org/2001/XMLSchema#string

M Shima

http://www.w3.org/2001/XMLSchema#string

T Matsumoto

http://www.w3.org/2001/XMLSchema#string

P2860

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin

Crystal structures of the membrane-binding C2 domain of human coagulation factor V

Calibrated automated thrombin generation measurement in clotting plasma

Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity

Clinical and laboratory manifestations of anti-factor V antibodies.

The factor V light chain mediates the binding and endocytosis of plasma-derived factor V by megakaryocytes.

Activation of factor VIII and mechanisms of cofactor action.

Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C.

Mutation in blood coagulation factor V associated with resistance to activated protein C.

P304

1503-1512

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JTH.12660

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25041532

http://www.w3.org/2001/XMLSchema#string

Coagulation function and mechanisms in various clinical phenotypes of patients with acquired factor V inhibitors.

about

P2860

P2860

Coagulation function and mechanisms in various clinical phenotypes of patients with acquired factor V inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698